178 related articles for article (PubMed ID: 9462921)
1. Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group.
Ashton LJ; Carr A; Cunningham PH; Roggensack M; McLean K; Law M; Robertson M; Cooper DA; Kaldor JM
AIDS Res Hum Retroviruses; 1998 Jan; 14(2):117-21. PubMed ID: 9462921
[TBL] [Abstract][Full Text] [Related]
2. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
[TBL] [Abstract][Full Text] [Related]
3. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons.
Bruisten SM; Frissen PH; Van Swieten P; Harrigan PR; Kinghorn I; Larder B; Weigel HM; De Vries E; Regez RM; Henrichs JH; Koot M; Huisman JG
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):327-35. PubMed ID: 9071432
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
[TBL] [Abstract][Full Text] [Related]
5. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
[TBL] [Abstract][Full Text] [Related]
6. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.
Lefrère JJ; Morand-Joubert L; Mariotti M; Bludau H; Burghoffer B; Petit JC; Roudot-Thoraval F
Blood; 1997 Aug; 90(3):1133-40. PubMed ID: 9242545
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
9. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
[TBL] [Abstract][Full Text] [Related]
10. Natural history of HIV-1 cell-free viremia.
Henrard DR; Phillips JF; Muenz LR; Blattner WA; Wiesner D; Eyster ME; Goedert JJ
JAMA; 1995 Aug; 274(7):554-8. PubMed ID: 7629984
[TBL] [Abstract][Full Text] [Related]
11. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection.
Lifson AR; Hessol NA; Buchbinder SP; O'Malley PM; Barnhart L; Segal M; Katz MH; Holmberg SD
Lancet; 1992 Jun; 339(8807):1436-40. PubMed ID: 1351128
[TBL] [Abstract][Full Text] [Related]
12. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
Sterling TR; Hoover DR; Astemborski J; Vlahov D; Bartlett JG; Schupbach J
J Infect Dis; 2002 Oct; 186(8):1181-5. PubMed ID: 12355373
[TBL] [Abstract][Full Text] [Related]
13. Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
Molina JM; Ferchal F; Chevret S; Barateau V; Poirot C; Morinet F; Modai J
AIDS; 1994 Jan; 8(1):27-33. PubMed ID: 7912084
[TBL] [Abstract][Full Text] [Related]
14. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.
Spijkerman IJ; Prins M; Goudsmit J; Veugelers PJ; Coutinho RA; Miedema F; de Wolf F
AIDS; 1997 Sep; 11(11):1383-8. PubMed ID: 9302449
[TBL] [Abstract][Full Text] [Related]
15. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection.
Pontesilli O; Carotenuto P; Kerkhof-Garde SR; Roos MT; Keet IP; Coutinho RA; Goudsmit J; Miedema F
AIDS Res Hum Retroviruses; 1999 Jul; 15(11):973-81. PubMed ID: 10445809
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
[TBL] [Abstract][Full Text] [Related]
18. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
[TBL] [Abstract][Full Text] [Related]
19. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV-infected injection drug users.
Zabay JM; Sempere JM; Benito JM; Gonzalez B; Obregón E; Díez J; Fernández-Cruz E
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):266-72. PubMed ID: 7859138
[TBL] [Abstract][Full Text] [Related]
20. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
Kim S; Hughes MD; Hammer SM; Jackson JB; DeGruttola V; Katzenstein DA
AIDS Res Hum Retroviruses; 2000 May; 16(7):645-53. PubMed ID: 10791875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
